These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 19925356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns.
    Guimarães H, Rocha G, Tomé T, Anatolitou F, Sarafidis K, Fanos V.
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():77-80. PubMed ID: 19925365
    [Abstract] [Full Text] [Related]

  • 3. Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension.
    Patole S, Lee J, Whitehall J.
    Indian Pediatr; 1998 Dec; 35(12):1221-4. PubMed ID: 10216700
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L.
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [Abstract] [Full Text] [Related]

  • 6. Update on management of patent ductus arteriosus in the preterm infant.
    Dani C.
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():1. PubMed ID: 21988761
    [No Abstract] [Full Text] [Related]

  • 7. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S, Limrungsikul A, Khowsathit P.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [Abstract] [Full Text] [Related]

  • 8. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH, Holden AM, Hurtado del Río D, Segura MA.
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I, Boubred F, Simeoni U.
    J Matern Fetal Neonatal Med; 2009 Aug; 22 Suppl 3():14-20. PubMed ID: 19925358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Indomethacin therapy for patent ductus arteriosus in premature infants.
    Lee KS.
    Pediatr Cardiol; 2008 Sep; 29(5):873-5. PubMed ID: 18401636
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Drug therapy of patent ductus arteriosus in premature and newborn infants].
    Bartel J.
    Kinderarztl Prax; 1978 Dec; 46(12):644-8. PubMed ID: 366238
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M, Beedgen B, Feneberg R, Huppertz C, Brüssau J, Pöschl J, Linderkamp O.
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [Abstract] [Full Text] [Related]

  • 20. High-dose indomethacin for patent ductus arteriosus closure: how strong is the evidence?
    Manzar S.
    Pediatrics; 2006 May; 117(5):1863; author reply 1863-4. PubMed ID: 16651359
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.